SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Remedent, Inc. – ‘10-Q’ for 12/31/20 – ‘EX-32.1’

On:  Tuesday, 2/16/21, at 4:30pm ET   ·   For:  12/31/20   ·   Accession #:  1104659-21-24103   ·   File #:  1-15975

Previous ‘10-Q’:  ‘10-Q’ on 11/16/20 for 9/30/20   ·   Latest ‘10-Q’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/21  Remedent, Inc.                    10-Q       12/31/20   66:4.2M                                   Toppan Merrill/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    180K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     24K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     24K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     19K 
12: R1          Document And Entity Information                     HTML     50K 
13: R2          Consolidated Balance Sheets                         HTML    110K 
14: R3          Consolidated Balance Sheets (Parenthetical)         HTML     41K 
15: R4          Consolidated Statements of Operations               HTML    107K 
16: R5          Consolidated Statements of Comprehensive Income     HTML     43K 
                (Loss)                                                           
17: R6          Consolidated Statements of Cash Flows               HTML     75K 
18: R7          Description of the Company and Basis of             HTML     25K 
                Presentation                                                     
19: R8          Summary of Significant Accounting Policies          HTML     57K 
20: R9          Long-Term Investments                               HTML     88K 
21: R10         Concentration of Risk                               HTML     23K 
22: R11         Accounts Receivable and Allowance for Doubtful      HTML     33K 
                Accounts                                                         
23: R12         Inventories                                         HTML     41K 
24: R13         Prepaid Expenses and Other Assets                   HTML     38K 
25: R14         Property and Equipment                              HTML     39K 
26: R15         Due to Related Parties and Related Party            HTML     23K 
                Transactions                                                     
27: R16         Accrued Liabilities                                 HTML     53K 
28: R17         Equity Compensation Plans                           HTML     67K 
29: R18         Segment Information                                 HTML     25K 
30: R19         Leases                                              HTML     70K 
31: R20         Financial Instruments                               HTML    108K 
32: R21         Summary of Significant Accounting Policies          HTML     70K 
                (Policies)                                                       
33: R22         Summary of Significant Accounting Policies          HTML     43K 
                (Tables)                                                         
34: R23         Long-Term Investments (Tables)                      HTML     78K 
35: R24         Accounts Receivable and Allowance for Doubtful      HTML     33K 
                Accounts (Tables)                                                
36: R25         Inventories (Tables)                                HTML     41K 
37: R26         Prepaid Expenses and Other Assets (Tables)          HTML     38K 
38: R27         Property and Equipment (Tables)                     HTML     38K 
39: R28         Accrued Liabilities (Tables)                        HTML     53K 
40: R29         Equity Compensation Plans (Tables)                  HTML     65K 
41: R30         Leases (Tables)                                     HTML     69K 
42: R31         Financial Instruments (Tables)                      HTML    107K 
43: R32         Description of the Company and Basis of             HTML     24K 
                Presentation (Details)                                           
44: R33         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     25K 
                Product warranty liability (Details)                             
45: R34         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     65K 
                Additional information (Details)                                 
46: R35         Long-Term Investments (Details)                     HTML     43K 
47: R36         Long-Term Investments - Summary of represent the    HTML     48K 
                summary financial information derived from its                   
                financial statements and prepared under US GAAP                  
                (Details)                                                        
48: R37         LONG-TERM INVESTMENTS - Additional information      HTML    251K 
                (Details)                                                        
49: R38         Concentration of Risk (Details)                     HTML     33K 
50: R39         Accounts Receivable and Allowance for Doubtful      HTML     26K 
                Accounts (Details)                                               
51: R40         Inventories (Details)                               HTML     32K 
52: R41         Prepaid Expenses and Other Assets (Details)         HTML     31K 
53: R42         Property and Equipment (Details)                    HTML     31K 
54: R43         Due to Related Parties and Related Party            HTML     21K 
                Transactions (Details)                                           
55: R44         Accrued Liabilities (Details)                       HTML     43K 
56: R45         EQUITY COMPENSATION PLANS - Equity compensation     HTML     27K 
                plans approved and not approved by shareholders                  
                (Details)                                                        
57: R46         EQUITY COMPENSATION PLANS - Additional information  HTML     25K 
                (Details)                                                        
58: R47         Segment Information (Details)                       HTML     20K 
59: R48         LEASES - Right-of-use assets and related            HTML     27K 
                liabilities (Details)                                            
60: R49         LEASES - Maturities of lease liabilities (Details)  HTML     33K 
61: R50         LEASES - Additional information (Details)           HTML     28K 
62: R51         FINANCIAL INSTRUMENTS - Carrying values and fair    HTML     63K 
                values (Details)                                                 
63: R52         FINANCIAL INSTRUMENTS - Additional information      HTML     26K 
                (Details)                                                        
65: XML         IDEA XML File -- Filing Summary                      XML    116K 
64: EXCEL       IDEA Workbook of Financial Reports                  XLSX     70K 
 6: EX-101.INS  XBRL Instance -- remi-20201231                       XML   1.24M 
 8: EX-101.CAL  XBRL Calculations -- remi-20201231_cal               XML    150K 
 9: EX-101.DEF  XBRL Definitions -- remi-20201231_def                XML    241K 
10: EX-101.LAB  XBRL Labels -- remi-20201231_lab                     XML    756K 
11: EX-101.PRE  XBRL Presentations -- remi-20201231_pre              XML    563K 
 7: EX-101.SCH  XBRL Schema -- remi-20201231                         XSD    135K 
66: ZIP         XBRL Zipped Folder -- 0001104659-21-024103-xbrl      Zip    105K 


‘EX-32.1’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Remedent, Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

1.           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date:     February 16, 2021 By: /s/ Guy De Vreese
    Name: Guy De Vreese
    Title: Chief Executive Officer
(Principal Executive Officer)

 

 C: 

 

 


Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:2/16/21None on these Dates
For Period end:12/31/20
 List all Filings 
Top
Filing Submission 0001104659-21-024103   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 12:24:29.1am ET